As ivermectin use has expanded dramatically — from its established role in FDA-approved antiparasitic treatment to off-label cancer adjunct protocols, COVID-19 research, and anti-ageing investigations — one question is increasingly asked by patients and clinicians: does ivermectin carry a risk to kidney function, and is it safe for the millions of Americans with chronic kidney disease (CKD)?